POM-V Prescription Required

Tulaven 100 mg/ml Solution for Injection for Cattle, Pigs and Sheep

Active ingredient: Tulathromycin

Form

Injection

Species

Cattle Pigs Sheep

Manufacturer

Ceva Animal Health Ltd

VMD MA No.

15052/5018

What it's used for

Cattle Treatment and metaphylaxis of bovine respiratory disease (BRD) associated withHistophilus somni ,Mannheimia haemolytica, Mycoplasma bovis group must...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Tulathromycin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Tulaven 100 mg/ml Solution for Injection for Cattle, Pigs and Sheep — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Cattle
Treatment and metaphylaxis of bovine respiratory disease (BRD) associated
withHistophilus somni ,Mannheimia haemolytica,
Mycoplasma bovis
group must be established before the product is used.
Treatment of infectious bovine keratoconjunctivitis (IBK) associated with
bovis
Pigs
Treatment and metaphylaxis of swine respiratory disease (SRD) associated with
Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Haemophilus parasuis
Pasteurella multocida and Mycoplasma hyopneumoniae
tulathromycin. The presence of the disease in the group must be established before
the product is used. The veterinary medicinal product should only be used if pigs
are expected to develop the disease within 2–3 days.

Revised: February 2025
AN: 02609/2023
Sheep
Treatment of the early stages of infectious pododermatitis (foot rot) associated with
virulent Dichelobacter nodosus requiring systemic treatment.

Do not use in cases of hypersensitivity to macrolide antibiotics or to any of the excipients.

Cattle:
Very common
(>1 animal / 10
animals treated)
Injection site swelling
, Injection site pain
,
Injection site oedema
, Injection site
fibrosis
, Injection site haemorrhage
,
Injection site haematoma
1
These signs are observed after subcutaneous administration.
These signs are reversible and can persist for approximately 30 days.
Pigs:
Very common
(>1 animal / 10 animals
treated)
Injection site oedema, Injection site fibrosis,
Injection site haemorrhage, Injection site
haematoma
These signs are reversible and can persist for approximately 30 days.
Sheep:
Very common
(>1 animal / 10 animals
treated)
Discomfort
1
Head shaking, rubbing injection site, backing away.
These signs appear after intramuscular injection and resolve within a few minutes.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

Cross resistance occurs with other macrolides. Do not administer simultaneously
with antimicrobials with a similar mode of action such as other macrolides or
lincosamides.
Sheep
The efficacy of antimicrobial treatment of foot rot might be reduced by other factors,
such as wet environmental conditions, as well as inappropriate farm management.
Treatment of foot rot should therefore be undertaken along with other flock
management tools, for example providing dry environment.
Antibiotic treatment of benign foot rot is not considered appropriate. Tulathromycin
showed limited efficacy in sheep with severe clinical signs or chronic foot rot and
should therefore only be given at an early stage of foot rot.

Special precautions for use in animals
Use of the veterinary medicinal product should be based on susceptibility testing of
the bacteria isolated from the animal. If this is not possible, therapy should be based
on local (regional, farm level) epidemiological information about susceptibility of the
target bacteria. Official, national and regional antimicrobial policies should be taken
into account when the product is used.
If a hypersensitivity reaction occurs, appropriate treatment should be administered
without delay.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Tulathromycin is irritating to eyes. In case of accidental eye exposure, flush the eyes
immediately with clean water.
Tulathromycin may cause sensitisation by skin contact resulting in e.g. reddening of
the skin (erythema) and/or dermatitis. In case of accidental spillage onto skin, wash
the skin immediately with soap and water.
Wash hands after use.

Revised: February 2025
AN: 02609/2023
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
If there is suspicion of a hypersensitivity reaction following accidental exposure
(recognised by e.g. itching, difficulty in breathing, hives, swelling on the face, nausea,
vomiting) appropriate treatment should be administered. Seek medical advice
immediately and show the package leaflet or the label to the physician.
Special precautions for the protection of the environment
Not applicable
Other precautions
Not applicable.

None known.

This veterinary medicinal product does not require any special storage conditions.

Cattle (meat and offal): 22 days.
Pigs (meat and offal): 13 days.
Sheep (meat and offal): 16 days.
Not authorised for use in animals producing milk for human consumption.
Do not use in pregnant animals, which are intended to produce milk for human
consumption, within 2 months of expected parturition.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.